An expert panel of the Central Drugs Standard Control Organisation had recently approved the antiviral Molnupiravir for restricted use in emergency situations, However, ICMR has raised concern over its side effects.
from Zee News :Zee News - Health https://ift.tt/3HVJTx0
https://ift.tt/eA8V8J
from Zee News :Zee News - Health https://ift.tt/3HVJTx0
https://ift.tt/eA8V8J
Molnupiravir benefits outweigh risk among Covid patients: Experts
![Molnupiravir benefits outweigh risk among Covid patients: Experts]()
Reviewed by fanaa news
on
January 11, 2022
Rating:
No comments: